Literature DB >> 6105113

Effects of secretin on glycogenolysis in cultured liver cells.

M Matsumura, H Akiyoshi.   

Abstract

Upon incubation of hepatocyte isolated from rats with secretin at concentration ranging from 0.1 unit to 1.0 unit per ml, glycogenolysis was maximally stimulated after 15 min. Somatostatin inhibited liver glycogenolysis. The combined addition to the incubation medium showed that somatostatin inhibited the stimulated glycogenolysis induced by secretin, while secretin plus vasoactive intestinal peptide showed no additive effects on glycogenolysis, as compared with single addition of secretin. However, the addition of glucagon to secretin showed additive effects on glycogenolysis. These results suggest that the receptor site for secretin might be different from that for glucagon, but the same as that for vasoactive intestinal peptide. Moreover, the calcium ion was shown to be a prerequisite for the inducible effects of the hormones so far tested.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 6105113     DOI: 10.1007/bf02774271

Source DB:  PubMed          Journal:  Gastroenterol Jpn        ISSN: 0435-1339


  10 in total

1.  Effects of somatostatin on pancreatic exocrine function. Interaction with secretin.

Authors:  P Robberecht; M Deschodt-Lanckman; P De Neef; J Christophe
Journal:  Biochem Biophys Res Commun       Date:  1975-11-03       Impact factor: 3.575

2.  Interactions of glucagon, gut glucagon, vasoactive intestinal polypeptide and secretin with liver and fat cell plasma membranes: binding to specific sites and stimulation of adenylate cyclase.

Authors:  D Bataille; P Freychet; G Rosselin
Journal:  Endocrinology       Date:  1974-09       Impact factor: 4.736

Review 3.  Insulin secretion: multifactorial regulation for a single process of release. The Minkowski award lecture delivered on September 7, 1972 before the European Association for the study of Diabetes at Madrid, Spain.

Authors:  W J Malaisse
Journal:  Diabetologia       Date:  1973-06       Impact factor: 10.122

4.  Vasoactive intestinal polypeptide and glucagon: stimulation of adenylate cyclase activity via distinct receptors in liver and fat cell membranes.

Authors:  B Desbuguois; M H Laudat; P Laudat
Journal:  Biochem Biophys Res Commun       Date:  1973-08-21       Impact factor: 3.575

5.  Calcium antagonists and islet function. I. Inhibition of insulin release by verapamil.

Authors:  G Devis; G Somers; E Van Obberghen; W J Malaisse
Journal:  Diabetes       Date:  1975-06       Impact factor: 9.461

6.  [Recent trends in the studies of somatostatin].

Authors:  A Arimura
Journal:  Horumon To Rinsho       Date:  1978-06

7.  Effects of vasoactive intestinal peptide on glycogenolysis in cultured liver cells.

Authors:  M Matsumura; H Akiyoshi; S Saito; H Mori
Journal:  Endocrinol Jpn       Date:  1979-04

8.  Secretin: high plasma levels in diabetes mellitus.

Authors:  E R Trimble; K D Buchanan; D R Hadden; D A Montgomery
Journal:  Acta Endocrinol (Copenh)       Date:  1977-08

9.  The effects of secretin, pancreozymin, and gastrin on insulin and glucagon secretion in anesthetized dogs.

Authors:  R H Unger; H Ketterer; J Dupré; A M Eisentraut
Journal:  J Clin Invest       Date:  1967-04       Impact factor: 14.808

10.  High-yield preparation of isolated rat liver parenchymal cells: a biochemical and fine structural study.

Authors:  M N Berry; D S Friend
Journal:  J Cell Biol       Date:  1969-12       Impact factor: 10.539

  10 in total
  1 in total

1.  Effects of somatostatin on gastrointestinal hormone-induced glycogenolysis and gluconeogenesis in cultured liver cells.

Authors:  M Matsumura; H Akiyoshi; S Saito
Journal:  Gastroenterol Jpn       Date:  1980
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.